Sir,
We read with great interest the study by Nunez-Enriquez et al (2013)’ recently published in this journal. They conducted a multi-institutional population-based case–control study on children with Down syndrome and found that asthma is a risk factor of acute leukaemia development (odds ratio: 4.18 and 95% confidence interval: 1.47–11.87). However, other allergies had no effect on acute leukaemia development or were protective, in their experience. This study has revived an old question about effect of having allergies and chance of cancer development. Previous studies in this regard unveiled that allergies usually do not increase the risk of cancers, and in contrast, might be protective from cancer development (Vojtechova and Martin, 2009; Chen et al, 2011; Dikalioti et al, 2012). In allergic subjects, there is bone marrow involvement with reprogramming of bone marrow stem cells, regarded as ‘reflex nature of allergic disease’ (Holt and Strickland, 2010). Allergic phenotype in an atopic child may lead to epigenetic reprogramming that in turn affects immune surveillance by increasing antigen-presenting cell activity (Holt and Strickland, 2010). In addition, recent studies have demonstrated that serum eosinophil count is inversely associated with colorectal cancer development (Prizment et al, 2011). Hence, it seems that increased surveillance by hyperactive immune system of allergic patients is a reality. Here, the main question is ‘why was asthma found as a risk factor of acute leukaemia development?’.
The method of allergy diagnosis and definition of allergic conditions affect categorisation of patients into different allergic groups, particularly with regard to recruitment of patients from different institutions. Moreover, considerable proportion of asthmatic patients might also have rhinitis, skin allergies or food allergies. Asthma and allergic rhinitis are too close in which more than half of asthmatic patients have also allergic rhinitis and up to 40% of allergic rhinitis patients experience asthma (Bousquet et al, 2012; Aryan et al, 2013). Skin allergies and food allergies are other allergic conditions that are common in asthmatics, in such a way up to 15% of asthmatics have food allergies (Fiocchi et al, 2013). It is not clear in this study that how investigators categorised patients who had several allergic conditions and it might affect their results.
Another point is that wheezing in Down syndrome children is not likely to be asthma and asthma misclassification is possible to be occurred. It has been shown that Down syndrome children might experience episodes of wheezing mimicking asthma phenotype. Weijerman et al 2011 studied recurrent wheeze in 173 Down syndrome children and found that none of Down syndrome children below 4 years of age had asthma according to international guidelines, and only 3.1% of overall Down syndrome children were actually asthmatic. Weijerman et al 2011 demonstrated that 46% of wheezes in Down syndrome children were due to congenital heart defects. In addition, neither of increased immunoglobulin-E level nor evidence of aeroallergen sensitisation was found in these children (Weijerman et al, 2011). Hence, the diagnosis of asthma should be made more carefully in Down syndrome patients and only reliance of parent’s memory might probably lead to misclassification of asthma in Down syndrome children. Moreover, not all asthmatic Down syndrome children have allergy, and in contrast, asthma in Down syndrome patients seem to be non-allergic (Weijerman et al, 2011). Collectively, the results of this study regarding asthma might be affected by misdiagnosis and misclassification of asthma as an allergic condition.
On the other hand, Down syndrome is a primary immune deficiency characterised by lymphopenia, thrombocytopenia, and vulnerability to autoimmune and infectious diseases. Down syndrome children have increased susceptibility to respiratory syncytial virus infections, a known risk factor of asthma, thus they may experience manifestations quasi-asthma or actually develop asthma (Bloemers et al, 2010). Down syndrome patients have also inherited risk of acute leukaemia development. Accumulating evidences show that several genes on chromosome 21 have relevant functions in haematopoiesis and their qualitative or quantitative changes affect blood cells. Transient abnormal haematopoiesis and acute myeloid leukaemia are more likely to develop in Down syndrome children with GATA1 mutation (Maclean et al, 2012; Toki et al, 2013). It indicates that regardless of role of environmental factors, inborn genetic defects in Down syndrome children affect haematopoietic cell biology and cause leukaemogenesis. Down syndrome might be a confounder in relation between asthma and acute leukemia. Altogether, Down syndrome may be considered as a cause of both asthma and acute leukaemia and drawing a causative link from asthma to acute leukaemia in this setting seems a raw conclusion.
References
Aryan Z, Comapalati E, Canonica GW, Rezaei N (2013) Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications. Expert Rev Vaccines 12 (6): 639–659.
Bloemers BL, van Furth AM, Weijerman ME, Gemke RJ, Broers CJ, Kimpen JL, Bont L (2010) High incidence of recurrent wheeze in children with down syndrome with and without previous respiratory syncytial virus lower respiratory tract infection. Pediatric Infect Dis J 29 (1): 39–42.
Bousquet J, Schunemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, Bonini S, Boulet LP, Bousquet PJ, Brozek JL, Canonica GW, Casale TB, Cruz AA, Fokkens WJ, Fonseca JA, van Wijk RG, Grouse L, Haahtela T, Khaltaev N, Kuna P, Lockey RF, Lodrup Carlsen KC, Mullol J, Naclerio R, O’Hehir RE, Ohta K, Palkonen S, Papadopoulos NG, Passalacqua G, Pawankar R, Price D, Ryan D, Simons FE, Togias A, Williams D, Yorgancioglu A, Yusuf OM, Aberer W, Adachi M, Agache I, Ait-Khaled N, Akdis CA, Andrianarisoa A, Annesi-Maesano I, Ansotegui IJ, Baiardini I, Bateman ED, Bedbrook A, Beghe B, Beji M, Bel EH, Ben Kheder A, Bennoor KS, Bergmann KC, Berrissoul F, Bieber T, Bindslev Jensen C, Blaiss MS, Boner AL, Bouchard J, Braido F, Brightling CE, Bush A, Caballero F, Calderon MA, Calvo MA, Camargos PA, Caraballo LR, Carlsen KH, Carr W, Cepeda AM, Cesario A, Chavannes NH, Chen YZ, Chiriac AM, Chivato Perez T, Chkhartishvili E, Ciprandi G, Costa DJ, Cox L, Custovic A, Dahl R, Darsow U, De Blay F, Deleanu D, Denburg JA, Devillier P, Didi T, Dokic D, Dolen WK, Douagui H, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, El-Meziane A, Emuzyte R, Fiocchi A, Fletcher M, Fukuda T, Gamkrelidze A, Gereda JE, Gonzalez Diaz S, Gotua M, Guzman MA, Hellings PW, Hellquist-Dahl B, Horak F, Hourihane JO, Howarth P, Humbert M, Ivancevich JC, Jackson C, Just J, Kalayci O, Kaliner MA, Kalyoncu AF, Keil T, Keith PK, Khayat G, Kim YY, Koffi N’goran B, Koppelman GH, Kowalski ML, Kull I, Kvedariene V, Larenas-Linnemann D, Le LT, Lemiere C, Li J, Lieberman P, Lipworth B, Mahboub B, Makela MJ, Martin F, Marshall GD, Martinez FD, Masjedi MR, Maurer M, Mavale-Manuel S, Mazon A, Melen E, Meltzer EO, Mendez NH, Merk H, Mihaltan F, Mohammad Y, Morais-Almeida M, Muraro A, Nafti S, Namazova-Baranova L, Nekam K, Neou A, Niggemann B, Nizankowska-Mogilnicka E, Nyembue TD, Okamoto Y, Okubo K, Orru MP, Ouedraogo S, Ozdemir C, Panzner P, Pali-Scholl I, Park HS, Pigearias B, Pohl W, Popov TA, Postma DS, Potter P, Rabe KF, Ratomaharo J, Reitamo S, Ring J, Roberts R, Rogala B, Romano A, Roman Rodriguez M, Rosado-Pinto J, Rosenwasser L, Rottem M, Sanchez-Borges M, Scadding GK, Schmid-Grendelmeier P, Sheikh A, qSisul JC, Sole D, Sooronbaev T, Spicak V, Spranger O, Stein RT, Stoloff SW, Sunyer J, Szczeklik A, Todo-Bom A, Toskala E, Tremblay Y, Valenta R, Valero AL, Valeyre D, Valiulis A, Valovirta E, Van Cauwenberge P, Vandenplas O, van Weel C, Vichyanond P, Viegi G, Wang DY, Wickman M, Wohrl S, Wright J, Yawn BP, Yiallouros PK, Zar HJ, Zernotti ME, Zhong N, Zidarn M, Zuberbier T (2012) Allergic rhinitis and its impact on asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol 130 (5): 1049–1062.
Chen C, Xu T, Chen J, Zhou J, Yan Y, Lu Y, Wu S (2011) Allergy and risk of glioma: a meta-analysis. Eur J Neurol 18 (3): 387–395.
Dikalioti SK, Chang ET, Dessypris N, Papadopoulou C, Skenderis N, Pourtsidis A, Moschovi M, Polychronopoulou S, Athanasiadou-Piperopoulou F, Sidi V, Kalmanti M, Petridou ET (2012) Allergy-associated symptoms in relation to childhood non-Hodgkin’s as contrasted to Hodgkin’s lymphomas: a case-control study in Greece and meta-analysis. Eur J Cancer 48 (12): 1860–1866.
Fiocchi A, Annunziato F, Assa’ad A, Arshad H, Bahna SL, Boyle R, Brozek J, Bush A, Canonica W, Cicardi M, Compalati E, Dahdah L, Dupont C, Finegold I, Fineman SM, Grabenhenrich L, Holgate S, Kuitunen M, Lau S, Maggi E, Martelli A, Matricardi P, Moretta L, Palmer D, Parronchi P, Pawankar R, Prescott S, Restani P, Rosenwasser L, Terracciano L, Scheurer S, Tripodi S, Vieths S, Von Berg A, Vultaggio A, Weber RW (2013) The management of paediatric allergy: not everybody’s cup of tea – 10–11th February 2012. Curr Opin Allergy Clin Immunol 13 (Suppl 1): S1–50.
Holt PG, Strickland DH (2010) Interactions between innate and adaptive immunity in asthma pathogenesis: new perspectives from studies on acute exacerbations. J Allergy Clin Immunol 125 (5): 963–972, quiz 973-974.
Maclean GA, Menne TF, Guo G, Sanchez DJ, Park IH, Daley GQ, Orkin SH (2012) Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc Natl Acad Sci USA 109 (43): 17567–17572.
Nunez-Enriquez JC, Fajardo-Gutierrez A, Buchan-Duran EP, Bernaldez-Rios R, Medina-Sanson A, Jimenez-Hernandez E, Amador-Sanchez R, Penaloza-Gonzalez JG, Paredes-Aguilera R, Alvarez-Rodriguez FJ, Bolea-Murga V, de Diego Flores-Chapa J, Flores-Lujano J, Bekker-Mendez VC, Rivera-Luna R, Del Carmen Rodriguez-Zepeda M, Rangel-Lopez A, Dorantes-Acosta EM, Nunez-Villegas N, Velazquez-Avina MM, Torres-Nava JR, Reyes-Zepeda NC, Cardenas-Cardos R, Flores-Villegas LV, Martinez-Avalos A, Salamanca-Gomez F, Gorodezky C, Arellano-Galindo J, Mejia-Arangure JM (2013) Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican inter-institutional group for the identification of the causes of childhood leukaemia. Br J Cancer 108 (11): 2334–2338.
Prizment AE, Anderson KE, Visvanathan K, Folsom AR (2011) Inverse association of eosinophil count with colorectal cancer incidence: atherosclerosis risk in communities study. Cancer Epidemiol, Biomarkers Prev 20 (9): 1861–1864.
Toki T, Kanezaki R, Kobayashi E, Kaneko H, Suzuki M, Wang R, Terui K, Kanegane H, Maeda M, Endo M, Mizuochi T, Adachi S, Hayashi Y, Yamamoto M, Shimizu R, Ito E (2013) Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome. Blood 121 (16): 3181–3184.
Vojtechova P, Martin RM (2009) The association of atopic diseases with breast, prostate, and colorectal cancers: a meta-analysis. Cancer Causes Control 20 (7): 1091–1105.
Weijerman ME, Brand PL, van Furth MA, Broers CJ, Gemke RJ (2011) Recurrent wheeze in children with Down syndrome: is it asthma? Acta Paediatrica 100 (11): e194–e197.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Aryan, Z., Rezaei, N. Comment on ‘Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican Inter Institutional Group for the Identification of the Causes of Childhood Leukaemia (MIGICCL)’ – Is increased surveillance by hypersensitive immune system a reality or myth?. Br J Cancer 109, 1386–1388 (2013). https://doi.org/10.1038/bjc.2013.435
Published:
Issue Date:
DOI: https://doi.org/10.1038/bjc.2013.435